TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

Ann: Board and Management Changes, page-4

  1. lilac
    3,590 Posts.
    lightbulb Created with Sketch. 333
    clock Created with Sketch.
    07/04/15
    12:14
    Post #: 15043029
    SM is barely mentioned in the release, except to say has resigned effective immediately.

    No thankyou, no acknowledgement....suffice to say Mr Clarke says TIS needs "focussed" leadership, and reiterates his strong commitment as a shareholder himself.

    Hopefully this means goodbye to the arrogance!
    TIS Price at posting: 11.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
NEWS Microcap Wrap: 5 explorers with news out today
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.